IN-VITRO CYTOLYTIC ACTIVITY OF LYMPHOCYTES FROM TUMOR-DRAINING LYMPH-NODES IS ASSOCIATED WITH INCREASED NUMBERS OF CD8+ CELLS AND INCREASEDCYTOKINE PRODUCTION

Citation
D. Holley et al., IN-VITRO CYTOLYTIC ACTIVITY OF LYMPHOCYTES FROM TUMOR-DRAINING LYMPH-NODES IS ASSOCIATED WITH INCREASED NUMBERS OF CD8+ CELLS AND INCREASEDCYTOKINE PRODUCTION, The Journal of surgical research, 58(1), 1995, pp. 33-37
Citations number
16
Categorie Soggetti
Surgery
ISSN journal
00224804
Volume
58
Issue
1
Year of publication
1995
Pages
33 - 37
Database
ISI
SICI code
0022-4804(1995)58:1<33:ICAOLF>2.0.ZU;2-L
Abstract
A murine footpad tumor model was used to determine the cytotoxic activ ity, tumor specificity, phenotypic profile, and cytokine production of stimulated cells from draining lymph nodes (DLN). Popliteal DLN from 5-day-old P-815 footpad tumors were stimulated with 10(-7) M phorbol 1 2, 13-dibutyrate + 5 X 10(-7) M ionomycin for 16 hr and cultured in IL -2 (20 units/ml) for 7 or 14 days without autologous tumor. Most cells in both groups were CD3(+) (93% at Day 7, 99% at Day 14); however, th e percentage of CD8(+) cells increased as the cell population matured in the presence of low-dose IL-2. On Day 7, the phenotypic profile was 62% CD4(+) and 29% CD8(+), whereas on Day 14 it was 16% CD4(+) and 81 % CD8(+). Similarly, in vitro cytokine production increased with time in culture. After 7 days, the Bevel of tumor necrosis factor-alpha (TN F-alpha) was 220 pg/mL and the interferon-gamma (IF-gamma) production was 150 pg/ml. At Day 14 the TNF level had increased to 500 pg/ml, and IF production had increased to 350 pg/ml. These increases in the CD8( +) population and in cytokine production correlated with the increase in the percentage of target cells killed by the DLN cells. Cytolytic a ctivity against P-815 was only 13% on Day 7 but 39% on Day 14. Neither group of effector cells (Day 7 or Day 14) had any cytolytic activity against the syngeneic tumor cell line L-1210, demonstrating the tumor specificity of the DLN cells. We describe a model for generating tumor -specific cytotoxic T-cells that have significant cytokine production, which may account for previously described in vivo activity. (C) 1995 Academic Press, Inc.